Nanobiotix is trading at $23.30, down 5.34%, amid reported selling pressure and a break below a watched support level.
- No new company-specific announcement explaining the October 8 move surfaced; the latest release was the October 1 CFO appointment.
- Higher yields and oil prices pressured broader markets; the Nasdaq was down 0.55% in the supplied market context.
- This backdrop may have contributed, but available reporting does not establish a direct cause for the U.S. share move.